Showing results (81-90 of 170) with videos related to
Sort By:
Pageof 17
Urology|October 30, 2025
"Benign" Pelvic Conditions Are Associated With High Costs and Frequent Overlapping SymptomatologyJoseph Visingardi, Fortis Gaba, Shreya Patel, et al.BMC Infectious Diseases|October 28, 2020
Who fails to return within 30 days after being tested positive for HIV/STI in a free testing centre?Camille Rolland, Elise de La Rochebrochard, Prescillia Piron, et al.Plos One|February 7, 2024
Medication abortion during the COVID-19 pandemic in France: A research based on the French national health insurance databaseJustine Chaput, Valentine Becquet, Pierre-Louis Bithorel, et al.Dyslexia (Chichester, England)|December 3, 2004
Early language development in children with a genetic risk of dyslexiaPetra van Alphen, Elise de Bree, Ellen Gerrits, et al.The Journal of International Advanced Otology|February 18, 2022
Hearing Loss in Malignant Infantile Osteopetrosis: A Case-Based ReviewElise De Cuyper, Céline De Cuyper, Leen Willems, et al.Experimental Physiology|July 22, 2025
Empagliflozin does not prevent progression of Dent's disease type 1 in a mouse modelElise de Combiens, Nadia Frachon, Yohan Bignon, et al.BMC Pregnancy and Childbirth|August 7, 2012
Joint modeling of success and treatment discontinuation in in vitro fertilization programs: a retrospective cohort studyPénélope Troude, Sophie Ancelet, Juliette Guibert, et al.European Journal of Cancer Care|November 4, 2022
Efficacy of interdisciplinary rehabilitation in child cancer survivors: Impact on physical fitness, fatigue and body composition after 1-year follow-upRuth Van der Looven, Elise De Vos, Kristof Vandekerckhove, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 12, 2020
Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort studyWakjira Kebede, Gemeda Abebe, Esayas Kebede Gudina, et al.Acta Clinica Belgica|November 28, 2018
Abiraterone and spironolactone in prostate cancer: a combination to avoidBert Dhondt, Sarah Buelens, Jeroen Van Besien, et al.Pageof 17